Loading...
ROCO
4167
Market cap185mUSD
Nov 12, Last price  
18.40TWD
Name

Savior Lifetec Corp

Chart & Performance

D1W1MN
ROCO:4167 chart
P/E
31.75
P/S
4.76
EPS
0.58
Div Yield, %
0.46%
Shrs. gr., 5y
3.24%
Rev. gr., 5y
-1.59%
Revenues
1.22b
+15.91%
786,335,000837,816,0001,000,632,0001,018,801,0001,120,609,0001,532,150,0001,618,119,0001,104,691,0001,318,694,0001,827,240,0001,743,785,0001,265,749,0001,050,277,0001,217,327,000
Net income
182m
+507.33%
-234,562,000-452,834,000-228,703,000-355,790,000-493,793,000-207,697,00022,273,000-359,547,000-44,047,000250,941,000-4,763,00020,616,00030,030,000182,380,000
CFO
518m
+33.62%
-458,821,000-227,587,000-85,389,000-92,409,000-415,816,000-76,090,000260,886,000-189,842,000156,401,00091,251,000-168,338,000581,772,000387,952,000518,378,000
Dividend
Jul 12, 20240.0851 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Savior Lifetec Corporation, a specialty injectable company, produces and supplies sterile APIs and finished dosage formulations. The company offers imipenem and cilastatin sodium, an antibacterial agent for intravenous infusion; and meropenem, a beta-lactamase resistant carbapenem antibiotic for parenteral administration. It also provides ertapenem, a form of carbapenem for use on gram-negative and gram-positive anaerobes and aerobic. The company's pipeline products include SLC-006 for prostate cancer endometriosis uterine leiomyoma; and sterile paliperidone palmitate API for the treatment of schizophrenia. Savior Lifetec Corporation was founded in 2004 and is headquartered in Miaoli County, Taiwan.
IPO date
Dec 21, 2012
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT